US FDA warns CordenPharma about Italian antibiotic API and cancer injectables plant
The US FDA was warned CordenPharma about manufacturing operations at a plant in Italy that was approved to make injectable cancer drugs last year.
The US FDA was warned CordenPharma about manufacturing operations at a plant in Italy that was approved to make injectable cancer drugs last year.
The CRO has opened new offices in Japan as part of its long-term growth strategy in the country – the world’s second largest pharmaceutical market.
Paid for and content provided by World Courier
Down at the base of Africa is a country with amazing heritage, unique geography, and challenging patient populations. See why clinical trials happen in South Africa here